Autopsy report · NCT00917826
Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies
Cause of deathNo reason given
Life of this trial
- Registered 9 months after it had already started.
- 1 participant enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- HemaQuest Pharmaceuticals Inc.
- Sponsor type
- Industry
- Conditions
- EBV Lymphomas; Lympho-proliferative Diseases
- Interventions
- Arginine Butyrate; Ganciclovir; Valganciclovir
- Participants
- 1
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.